search
Back to results

Food Intake and Epigenetic Alteration in the Spermatozoa of Singletons and Twins (FEASST)

Primary Purpose

Fertility Issues, Nutrition, Healthy, Epigenetic Disorder

Status
Active
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Isocaloric Unprocessed Diet
Isocaloric Processed Diet
Excess Calorie Unprocessed Diet
Excess Calorie Processed Diet
Sponsored by
University of Copenhagen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Fertility Issues

Eligibility Criteria

20 Years - 35 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Male
  • 20 to 35 years old
  • BMI 18.5 to 30
  • Located within the Copenhagen region
  • Fluent in English and/or Danish language
  • Sperm concentration of >15 mil/mL according to the WHO's criteria for semen quality
  • Semen volume of >1.5mL mL according to the WHO's criteria for semen quality
  • Clinician approval for participation in study
  • Obtained informed consent

Exclusion Criteria:

  • Self-reported history of serious or chronic illness
  • Self-reported history of Obesity
  • History of any food restrictions
  • History of allergies to any food products
  • History of disordered eating
  • Record of current use of drugs, alcohol (>14 units per week and/or chronic binge drinking), and/or tobacco/nicotine products within the past month
  • Current use of prescription medication
  • Engage in > 200 minutes of vigorous aerobic exercise per week
  • Currently actively trying to conceive a child
  • Diagnosis of infertility or disease of the reproductive system
  • Evidence of dysregulated metabolism, characterized by the occurrence of any one of the following:

    • Waist circumference >102 cm
    • Blood pressure > 130/85 mm Hg

Sites / Locations

  • University of Copenhagen

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Isocaloric Arm

Excess Calorie Arm

Arm Description

Participants within the isocaloric arm will be provided with food provisions in accordance with their nutrition needs. Participants within this arm will be further randomised to the order of first and second dietary interventions for the crossover design; unprocessed diet or processed diet.

Participants within the excess calorie arm will be provided with food provisions in accordance with their nutrition needs plus an additional 500 kilocalories per day. Participants within this arm will be further randomised to the order of first and second dietary interventions for the crossover design; unprocessed diet or processed diet.

Outcomes

Primary Outcome Measures

Spermatozoa DNA Methylation via Reduced Representation Bisulfite Sequencing
Differential methylation of CpG sites within mature spermatozoa determined from extracted genomic DNA which has undergone library preperation with Ovation® RRBS Methyl-Seq (NuGEN Technologies) and sequenced on a NextSeq Illumina platform.

Secondary Outcome Measures

Sperm Concentration
Measured in million sperm per mL using LensHooke X1 Pro Semen Quality Analyser and Microscopy-based methodology
Semen Volume
Measured in mL assuming the density of semen to be 1 g/ml
Sperm Motility
Measured in precent of sperm classified as progressively motile and non-progressively motile using LensHooke X1 Pro Semen Quality Analyser and Microscopy-based methodology
Spermatozoa smallRNA expression via sequencing of total smallRNA species
Differential expression of small RNA species within mature spermatozoa performed by generation of RNA sequencing libraries using NEXTFLEX® Small RNA-Seq Kit for Illumina (PerkinElmer), according to the manufacturer's instructions, and sequenced on a NextSeq Illumina platform.
Height
Measured in meters using a stadiometer (Charder HM-200P Portstad)
Weight
Measured in kilograms using a scale (Tanita DC 430 SMA)
Body Mass Index (BMI)
Calculated based on height and weight measurement using the equation BMI=kg/m^2
Waist Circumference
Measured in centimetres using a flexible measuring tape (SECA Measuring Tape 201 cm)
Hip Circumference
Measured in centimetres using a flexible measuring tape (SECA Measuring Tape 201 cm)
Body Fat Precentage
Measured using DEXA Scanner and Software (GE Lunar Prodigy)
C-reactive protein (CRP)
Measured in milligrams per litre in serum
Lipoproteins
Measuring high density lipoproteins and low density lipoproteins in milligrams per litre in plasma
Total protein
Measured in grams per litre in serum
Testosterone
Measured in nanograms per deciliter in plasma
Follicle stimulating hormone (FSH)
Measured in international units per milliliter in serum
Luteinizing hormone (LH)
Measured in international units per liters in plasma
Progesterone
Measured in nanograms per milliliter in serum
Estradiol
Measured in picograms per milliliter in serum
Oestradiol
Measured in picograms per milliliter in serum
Fasting Blood Glucose
Measured in whole blood using a handheld glucometer and test strip (Contour next Blood Glucose Meter and Blood Sugar Test strip)
Insulin
Measured in microunits per milliliter in serum
Haemoglobin A1c (HbA1c)
Measured in mmol/mol in plasma
Blood pressure
Systolic and Diastolic blood pressure measured in mmHg using an automatic blood pressure cuff (Omron M6 Comfort Automatic Upper Arm Blood Pressure Monitor, 22-42cm)
Leptin
Measured in ng/mL in plasma
Adiponectin
Measured in μg/mL in serum
Glucagon-like peptide 1 (GLP-1)
Measured in pmol/L in plasma
Gastric inhibitory peptide (GIP)
Measured in pg/mL in serum
Glucagon
Measured in pg/mL in serum
Ghrelin
Measured in pg/mL in plasma
Peptide YY (PYY)
Measured in ng/L in plasma
Fibroblast growth factor 21 (FGF-21)
Measured in pg/ml in serum
Peripheral blood mononuclear cell (PBMC) DNA methylation via Reduced Representation Bisulfite Sequencing
Differential methylation of CpG sites within PBMCs determined from extracted genomic DNA which has undergone library preperation with Ovation® RRBS Methyl-Seq (NuGEN Technologies) and sequenced on a NextSeq Illumina platform.

Full Information

First Posted
December 16, 2021
Last Updated
November 2, 2022
Sponsor
University of Copenhagen
Collaborators
Deakin University, Monash Health
search

1. Study Identification

Unique Protocol Identification Number
NCT05368194
Brief Title
Food Intake and Epigenetic Alteration in the Spermatozoa of Singletons and Twins
Acronym
FEASST
Official Title
The FEASST Study: Food Intake and Epigenetic Alteration in the Spermatozoa of Singletons and Twins
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
October 20, 2021 (Actual)
Primary Completion Date
July 1, 2022 (Actual)
Study Completion Date
December 31, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Copenhagen
Collaborators
Deakin University, Monash Health

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to elucidate the role of acute dietary intake in male populations, and its impact on spermatozoa quality, integrity, content and epigenetic programming.
Detailed Description
The FEASST study has been designed to determine the impact of diet on the content, quality, and genetic programming of sperm. They are specifically interested in determining if a man's diet plays a role in influencing the health of his potential, future offspring through modifications of the sperm. Previous research has highlighted that certain dietary patterns in fathers-to-be may lead to variable health outcome for their children. However, the specific effect of a man's diet has yet to be fully understood. This study will help understand the impact of a man's diet on semen quality and potential downstream implications for child health, to aid in the development of dietary guidelines for future fathers-to-be. For this study, male participants will be provided with two prescribed diets for three-week increments punctuated by a three month break. Health information and biological samples such as blood, semen, and saliva will be collected from study participants throughout the five month period. The diets will consist of a 'Processed diet', mimicking a traditional Western dietary intake pattern and an 'Unprocessed diet', based upon current dietary guidelines at quantities either adequate for the participants energetic needs or 500 calories in excess per day. Patient information and samples will be collected before and after each dietary intervention. Aspects of patient health examined at various time points include weight, body fat percentage, sperm quality, epigenetic sequencing, serum levels of metabolic parameters, and survey information surrounding health history, typical diet, physical activity patterns, and treatment adherence.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fertility Issues, Nutrition, Healthy, Epigenetic Disorder, Overnutrition

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
43 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Isocaloric Arm
Arm Type
Experimental
Arm Description
Participants within the isocaloric arm will be provided with food provisions in accordance with their nutrition needs. Participants within this arm will be further randomised to the order of first and second dietary interventions for the crossover design; unprocessed diet or processed diet.
Arm Title
Excess Calorie Arm
Arm Type
Experimental
Arm Description
Participants within the excess calorie arm will be provided with food provisions in accordance with their nutrition needs plus an additional 500 kilocalories per day. Participants within this arm will be further randomised to the order of first and second dietary interventions for the crossover design; unprocessed diet or processed diet.
Intervention Type
Dietary Supplement
Intervention Name(s)
Isocaloric Unprocessed Diet
Intervention Description
Intervention consists of an unprocessed diet meeting the Nordic and Australian Dietary Guidelines for food groups and micronutrients, wherein participants will be supplied with food providing kilocalories (kcal) in accordance with their nutritional needs as calculated based on theSchofield equation based on their weight, activity multiplier, and age at baseline. Almost all food and beverage products provided during this treatment to fall into the category of unprocessed/minimally processed foods and processed culinary ingredients in accordance with the NOVA classification system.
Intervention Type
Dietary Supplement
Intervention Name(s)
Isocaloric Processed Diet
Intervention Description
Intervention consists of a processed diet based on the dietary intake pattern resembling a processed western dietary intake pattern representative of the typical intake pattern of American men aged 19- 50, wherein participants will be supplied with food providing kcals in accordance with their nutritional needs as calculated based on the Schofield equation based on their height, weight, activity multiplier, and age at baseline. Almost all food and beverage products provided during this treatment to fall into the category of processed foods and ultra-processed foods in accordance with the NOVA classification system.
Intervention Type
Dietary Supplement
Intervention Name(s)
Excess Calorie Unprocessed Diet
Intervention Description
Intervention consists of an unprocessed diet meeting the Nordic and Australian Dietary Guidelines for food groups and micronutrients, wherein participants will be supplied with food providing kilocalories (kcal) in accordance with their nutritional needs as calculated based on theSchofield equation based on their weight, activity multiplier, and age at baseline, plus an excess of 500 kcal per day. Almost all food and beverage products provided during this treatment to fall into the category of unprocessed/minimally processed foods and processed culinary ingredients in accordance with the NOVA classification system.
Intervention Type
Dietary Supplement
Intervention Name(s)
Excess Calorie Processed Diet
Intervention Description
Intervention consists of a processed diet based on the dietary intake pattern resembling a processed western dietary intake pattern representative of the typical intake pattern of American men aged 19- 50, wherein participants will be supplied with food providing kcals in accordance with their nutritional needs as calculated based on the Schofield equation based on their height, weight, activity multiplier, and age at baseline, plus an excess of 500 kcal per day. Almost all food and beverage products provided during this treatment to fall into the category of processed foods and ultra-processed foods in accordance with the NOVA classification system.
Primary Outcome Measure Information:
Title
Spermatozoa DNA Methylation via Reduced Representation Bisulfite Sequencing
Description
Differential methylation of CpG sites within mature spermatozoa determined from extracted genomic DNA which has undergone library preperation with Ovation® RRBS Methyl-Seq (NuGEN Technologies) and sequenced on a NextSeq Illumina platform.
Time Frame
3 weeks
Secondary Outcome Measure Information:
Title
Sperm Concentration
Description
Measured in million sperm per mL using LensHooke X1 Pro Semen Quality Analyser and Microscopy-based methodology
Time Frame
3 weeks
Title
Semen Volume
Description
Measured in mL assuming the density of semen to be 1 g/ml
Time Frame
3 weeks
Title
Sperm Motility
Description
Measured in precent of sperm classified as progressively motile and non-progressively motile using LensHooke X1 Pro Semen Quality Analyser and Microscopy-based methodology
Time Frame
3 weeks
Title
Spermatozoa smallRNA expression via sequencing of total smallRNA species
Description
Differential expression of small RNA species within mature spermatozoa performed by generation of RNA sequencing libraries using NEXTFLEX® Small RNA-Seq Kit for Illumina (PerkinElmer), according to the manufacturer's instructions, and sequenced on a NextSeq Illumina platform.
Time Frame
3 weeks
Title
Height
Description
Measured in meters using a stadiometer (Charder HM-200P Portstad)
Time Frame
3 weeks
Title
Weight
Description
Measured in kilograms using a scale (Tanita DC 430 SMA)
Time Frame
3 weeks
Title
Body Mass Index (BMI)
Description
Calculated based on height and weight measurement using the equation BMI=kg/m^2
Time Frame
3 weeks
Title
Waist Circumference
Description
Measured in centimetres using a flexible measuring tape (SECA Measuring Tape 201 cm)
Time Frame
3 weeks
Title
Hip Circumference
Description
Measured in centimetres using a flexible measuring tape (SECA Measuring Tape 201 cm)
Time Frame
3 weeks
Title
Body Fat Precentage
Description
Measured using DEXA Scanner and Software (GE Lunar Prodigy)
Time Frame
3 weeks
Title
C-reactive protein (CRP)
Description
Measured in milligrams per litre in serum
Time Frame
3 weeks
Title
Lipoproteins
Description
Measuring high density lipoproteins and low density lipoproteins in milligrams per litre in plasma
Time Frame
3 weeks
Title
Total protein
Description
Measured in grams per litre in serum
Time Frame
3 weeks
Title
Testosterone
Description
Measured in nanograms per deciliter in plasma
Time Frame
3 weeks
Title
Follicle stimulating hormone (FSH)
Description
Measured in international units per milliliter in serum
Time Frame
3 weeks
Title
Luteinizing hormone (LH)
Description
Measured in international units per liters in plasma
Time Frame
3 weeks
Title
Progesterone
Description
Measured in nanograms per milliliter in serum
Time Frame
3 weeks
Title
Estradiol
Description
Measured in picograms per milliliter in serum
Time Frame
3 weeks
Title
Oestradiol
Description
Measured in picograms per milliliter in serum
Time Frame
3 weeks
Title
Fasting Blood Glucose
Description
Measured in whole blood using a handheld glucometer and test strip (Contour next Blood Glucose Meter and Blood Sugar Test strip)
Time Frame
3 weeks
Title
Insulin
Description
Measured in microunits per milliliter in serum
Time Frame
3 weeks
Title
Haemoglobin A1c (HbA1c)
Description
Measured in mmol/mol in plasma
Time Frame
3 weeks
Title
Blood pressure
Description
Systolic and Diastolic blood pressure measured in mmHg using an automatic blood pressure cuff (Omron M6 Comfort Automatic Upper Arm Blood Pressure Monitor, 22-42cm)
Time Frame
3 weeks
Title
Leptin
Description
Measured in ng/mL in plasma
Time Frame
3 weeks
Title
Adiponectin
Description
Measured in μg/mL in serum
Time Frame
3 weeks
Title
Glucagon-like peptide 1 (GLP-1)
Description
Measured in pmol/L in plasma
Time Frame
3 weeks
Title
Gastric inhibitory peptide (GIP)
Description
Measured in pg/mL in serum
Time Frame
3 weeks
Title
Glucagon
Description
Measured in pg/mL in serum
Time Frame
3 weeks
Title
Ghrelin
Description
Measured in pg/mL in plasma
Time Frame
3 weeks
Title
Peptide YY (PYY)
Description
Measured in ng/L in plasma
Time Frame
3 weeks
Title
Fibroblast growth factor 21 (FGF-21)
Description
Measured in pg/ml in serum
Time Frame
3 weeks
Title
Peripheral blood mononuclear cell (PBMC) DNA methylation via Reduced Representation Bisulfite Sequencing
Description
Differential methylation of CpG sites within PBMCs determined from extracted genomic DNA which has undergone library preperation with Ovation® RRBS Methyl-Seq (NuGEN Technologies) and sequenced on a NextSeq Illumina platform.
Time Frame
3 weeks

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Male 20 to 35 years old BMI 18.5 to 30 Located within the Copenhagen region Fluent in English and/or Danish language Sperm concentration of >15 mil/mL according to the WHO's criteria for semen quality Semen volume of >1.5mL mL according to the WHO's criteria for semen quality Clinician approval for participation in study Obtained informed consent Exclusion Criteria: Self-reported history of serious or chronic illness Self-reported history of Obesity History of any food restrictions History of allergies to any food products History of disordered eating Record of current use of drugs, alcohol (>14 units per week and/or chronic binge drinking), and/or tobacco/nicotine products within the past month Current use of prescription medication Engage in > 200 minutes of vigorous aerobic exercise per week Currently actively trying to conceive a child Diagnosis of infertility or disease of the reproductive system Evidence of dysregulated metabolism, characterized by the occurrence of any one of the following: Waist circumference >102 cm Blood pressure > 130/85 mm Hg
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Romain Barrès, PhD
Organizational Affiliation
University of Copenhagen Novo Nordisk Foundation Center for Basic Metabolic Research
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Copenhagen
City
Copenhagen
ZIP/Postal Code
2200
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Food Intake and Epigenetic Alteration in the Spermatozoa of Singletons and Twins

We'll reach out to this number within 24 hrs